Cargando…
Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation
BACKGROUND: Traditional Chinese medicine has been used for a long time to treat a variety of gynecological diseases. Among various traditional Chinese medicine, Dingkun Pill (DK) has been used for the treatment of female gynecological diseases. However, DK therapeutic effect on PCOS and the target t...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463533/ https://www.ncbi.nlm.nih.gov/pubmed/37633943 http://dx.doi.org/10.1186/s13048-023-01215-0 |
_version_ | 1785098254989393920 |
---|---|
author | Gu, Mengqing Cai, Han Deng, Weinan Tang, Yedong Du, Shuailin Wang, Peiran Deng, Wenbo Wang, Haibin Sun, Aijun Kong, Shuangbo |
author_facet | Gu, Mengqing Cai, Han Deng, Weinan Tang, Yedong Du, Shuailin Wang, Peiran Deng, Wenbo Wang, Haibin Sun, Aijun Kong, Shuangbo |
author_sort | Gu, Mengqing |
collection | PubMed |
description | BACKGROUND: Traditional Chinese medicine has been used for a long time to treat a variety of gynecological diseases. Among various traditional Chinese medicine, Dingkun Pill (DK) has been used for the treatment of female gynecological diseases. However, DK therapeutic effect on PCOS and the target tissue for its potential effect need to be explored. This study aims to explore the therapeutic effect of DK for PCOS in mice from three aspects: metabolism, endocrine and fertility, and determine whether the brown adipose tissue is the target organ to alleviate the PCOS phenotype. METHODS: PCOS mouse model was constructed by subcutaneous injection of DHEA. The estrous cycle, ovulation, and pregnancy outcome was examined in mice. The level of hormone including the LH, FSH, estrogen and testosterone in the serum were measured by ELISA. Both the glucose sensitivity and insulin sensitivity were determined in mice with different treatment. The histomorphology and lipid contents in the brown adipose tissue were analyzed. RNA-Seq was conducted for the brown adipose tissue and different expression of critical metabolism marker genes was confirmed by real-time PCR. RESULTS: The data showed that the fertility in PCOS mice with DK treatment was significantly increased, and the metabolic disorder was partially restored. Both the whiten of brown adipose tissue and reduced UCP1 expression induced by DHEA was rescued by the DK. The RNA-Seq data further demonstrated both the DHEA induced downregulation of lipolysis genes and oxidative phosphorylation genes were at least partially rescued by DK in the brown adipose tissue. CONCLUSIONS: DK has therapeutic effect on PCOS in DHEA treated mice and the brown adipose tissue is at least one critical target organ to alleviate the PCOS. This is achieved by not only regulating the lipid mobilization of brown adipose, but also restoring its thermogenic function. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13048-023-01215-0. |
format | Online Article Text |
id | pubmed-10463533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-104635332023-08-30 Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation Gu, Mengqing Cai, Han Deng, Weinan Tang, Yedong Du, Shuailin Wang, Peiran Deng, Wenbo Wang, Haibin Sun, Aijun Kong, Shuangbo J Ovarian Res Research BACKGROUND: Traditional Chinese medicine has been used for a long time to treat a variety of gynecological diseases. Among various traditional Chinese medicine, Dingkun Pill (DK) has been used for the treatment of female gynecological diseases. However, DK therapeutic effect on PCOS and the target tissue for its potential effect need to be explored. This study aims to explore the therapeutic effect of DK for PCOS in mice from three aspects: metabolism, endocrine and fertility, and determine whether the brown adipose tissue is the target organ to alleviate the PCOS phenotype. METHODS: PCOS mouse model was constructed by subcutaneous injection of DHEA. The estrous cycle, ovulation, and pregnancy outcome was examined in mice. The level of hormone including the LH, FSH, estrogen and testosterone in the serum were measured by ELISA. Both the glucose sensitivity and insulin sensitivity were determined in mice with different treatment. The histomorphology and lipid contents in the brown adipose tissue were analyzed. RNA-Seq was conducted for the brown adipose tissue and different expression of critical metabolism marker genes was confirmed by real-time PCR. RESULTS: The data showed that the fertility in PCOS mice with DK treatment was significantly increased, and the metabolic disorder was partially restored. Both the whiten of brown adipose tissue and reduced UCP1 expression induced by DHEA was rescued by the DK. The RNA-Seq data further demonstrated both the DHEA induced downregulation of lipolysis genes and oxidative phosphorylation genes were at least partially rescued by DK in the brown adipose tissue. CONCLUSIONS: DK has therapeutic effect on PCOS in DHEA treated mice and the brown adipose tissue is at least one critical target organ to alleviate the PCOS. This is achieved by not only regulating the lipid mobilization of brown adipose, but also restoring its thermogenic function. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13048-023-01215-0. BioMed Central 2023-08-26 /pmc/articles/PMC10463533/ /pubmed/37633943 http://dx.doi.org/10.1186/s13048-023-01215-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Gu, Mengqing Cai, Han Deng, Weinan Tang, Yedong Du, Shuailin Wang, Peiran Deng, Wenbo Wang, Haibin Sun, Aijun Kong, Shuangbo Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation |
title | Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation |
title_full | Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation |
title_fullStr | Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation |
title_full_unstemmed | Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation |
title_short | Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation |
title_sort | dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463533/ https://www.ncbi.nlm.nih.gov/pubmed/37633943 http://dx.doi.org/10.1186/s13048-023-01215-0 |
work_keys_str_mv | AT gumengqing dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT caihan dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT dengweinan dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT tangyedong dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT dushuailin dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT wangpeiran dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT dengwenbo dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT wanghaibin dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT sunaijun dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation AT kongshuangbo dingkunpillalleviatesmetabolicabnormalitiesinpolycysticovarysyndromethroughbrownadiposetissueactivation |